Fixvel
Fixvel is the global first generic oral tablet for pan-genotypic Chronic Hepatitis C treatment. This combination (Sofosbuvir 400 mg + Valpatasvir 100 mg) drug has been approved by US FDA & European Commission for treatment of patients with all genotypic Chronic Hepatitis C virus infection. Fixvel is used without cirrhosis or with compensated cirrhosis, and patients with advanced cirrhosis (Decompensated).
Features
| Product Name | Fixvel |
| Generic Name | Sofosbuvir 400mg + Velpatasvir 100 mg |
| Therapeutic Class | Antiviral |
| Formulation | Tablet |
| Available Pack Size | 1×6’s |
| Available Strength | 400mg+ 100mg (Combination) |